Piperacillin Sodium/Enmetazobactam

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePiperacillin Sodium/Enmetazobactam
Drug Alias NameAAI-101+PiperacillinPiperacillin+AAI-101Piperacillin/AAI-101
ClassificationSmall molecules
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Piperacillin SodiumEnmetazobactam
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOrchidAllecra
China Registration ClassN/A

Develop Information

Active CompaniesOrchidAllecra
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A